Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

OrbiMed Discloses 12.3% Stake in Aspen Neuroscience IPO

OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC filed a Schedule 13D with the SEC on November 6, 2026, disclosing beneficial ownership of 3,589,132 shares of Aspen Neuroscience, Inc. common stock following the company's initial public offering, with the triggering event dated November …

Aakashdeep | 06 November 2026

Richard Kinder Buys 500,000 KMI Shares at $29.9884

Executive Chairman Richard D. Kinder filed a Form 4 with the SEC on November 6, 2026, disclosing a purchase of 500,000 shares of Kinder Morgan, Inc. Class P Common Stock at a weighted average price of $29.9884 per share.

Anjali Anand | 06 November 2026

Harraden Circle Reports 13.89% Stake in Calisa Acquisition

Harraden Circle Investments, LLC and Frederick V. Fortmiller, Jr. filed an amended beneficial ownership statement with the SEC on November 6, 2026, disclosing a combined 13.89% stake in Calisa Acquisition Corp's Ordinary Shares as of October 31, 2026.

Vinay Lochav | 06 November 2026

Harraden Circle Discloses 6.4% Stake in Calisa Acquisition

Harraden Circle Investments, LLC and Frederick V. Fortmiller, Jr. filed a Schedule 13G with the SEC on November 6, 2026, disclosing a beneficial ownership position in the Ordinary Shares of Calisa Acquisition Corp as of September 30, 2026.

Nitish Kishor | 06 November 2026

Harraden Circle Discloses 12.99% Stake in Texas Ventures III

Harraden Circle Investments, LLC and Frederick V. Fortmiller, Jr. filed a Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of Class A shares of Texas Ventures Acquisition III Corp as of October 31, 2026.

Anjali Anand | 06 November 2026

Qualys CFO Kim Joo Mi Receives 26,179 RSUs at $0

Qualys, Inc. Chief Financial Officer Joo Mi Kim reported the acquisition of 26,179 restricted stock units on November 5, 2026, in a statement of changes in beneficial ownership filed with the SEC on November 6, 2026.

Shwetambri Chauhan | 06 November 2026

Bruce Posey Gets 15,241 Qualys RSUs at No Cost

Qualys, Inc. Chief Legal Officer Bruce K. Posey reported the acquisition of 15,241 restricted stock units on November 5, 2026, in a statement of changes in beneficial ownership filed with the SEC on November 6, 2026.

Aditi Sarkar | 06 November 2026

Dirk Van de Put Exercises 129,285 MDLZ Options in Nov 2026

Mondelez International, Inc. Chief Executive Officer and Director Dirk Van de Put filed a Form 4 on November 6, 2026, disclosing the exercise of stock options and same-day sales of Class A Common Stock on November 4 and 5, 2026, pursuant to a Rule …

Aakashdeep | 06 November 2026

Sprouts CEO Sinclair Sells 21,576 Shares Over Nov 4-5

Jack Sinclair, Chief Executive Officer and Director of Sprouts Farmers Market, Inc., filed a Form 4 on November 6, 2026, disclosing the exercise of stock options and sale of common stock on November 4 and November 5, 2026, pursuant to a Rule 10b5-1 trading …

Vinay Lochav | 06 November 2026

Eizen Sells 2,826 AN2 Therapeutics Shares for Tax Withholding

Joshua M. Eizen, Chief Operating Officer and Chief Legal Officer of AN2 Therapeutics, Inc., filed a Form 4 on November 6, 2026, disclosing a sale of common stock on November 5, 2026, to cover tax withholding obligations from vesting RSUs.

Vinay Lochav | 06 November 2026
Support

Hi! How can we help you today?

Loading…